skip to content
Thank you for visiting First Coast Service Options' Medicare provider website. This website is intended exclusively for Medicare providers and health care industry professionals to find the latest Medicare news and information affecting the provider community.
To enable us to present you with customized content that focuses on your area of interest, please select your preferences below:
Select which best describes you:
Select your location:
Select your line of business:
This website provides information and news about the Medicare program for health care professionals only. All communication and issues regarding your Medicare benefits are handled directly by Medicare and not through this website. Information for Medicare beneficiaries is only available on the medicare.gov website.
En Español
Text Size:
Send a link to this page
[Multiple email adresses must be separated by a semicolon.]

Active LCDs

Modified: 4/30/2018
LCD L33256 3D Interpretation and Reporting of Imaging Studies, Part AB
Modified: 4/30/2018
Revision 1 to LCD L33257 Abatacept, Part AB
Modified: 5/25/2018
LCD L33804 Allergen Immunotherapy, Part B
Modified: 4/30/2018
2018 HCPCS updates effective on 01/01/2018.
Modified: 4/30/2018
LCD L36237 Amniotic Membrane - Sutureless Placement on the Ocular Surface, Part AB
Modified: 4/19/2018
LCD L33263 Anorectal Manometry and EMG of the Urinary and Anal Sphincters, Part AB
Modified: 6/4/2018
Aortography and peripheral angiography (L36767), Part AB
Modified: 4/30/2018
LCD L36377 Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities, Part AB
Modified: 5/28/2018
L33609 Autonomic Function Tests, Part AB
Modified: 5/28/2018
LCD L33266 Azacitidine (Vidaza®), Part AB
Modified: 6/5/2018
LCD L33904 B-Scan, Part B
Modified: 5/28/2018
LCD L33267 B-Type Natriuretic Peptide (BNP), Part AB
Modified: 5/28/2018
BRCA1 and BRCA2 Genetic Testing (L36499), Part AB
Modified: 6/5/2018
LCD L33268 Bendamustine hydrochloride (Treanda®, Bendeka ™) Part AB
Modified: 5/28/2018
LCD L33615 Biofeedback, Part AB
Modified: 7/12/2018
LCD L33270 Bisphosphonates (Intravenous [IV]) and Monoclonal Antibodies in the Treatment of Osteoporosis and Their Other Indications / Part A/B
Modified: 6/12/2018
LCD L33271 Biventricular Pacing/ Cardiac Resynchronization Therapy, Part AB
Modified: 5/28/2018
LCD L33272 Bone and/or Joint Imaging, Part A/B
Modified: 5/4/2018
LCD L36356 Bone mineral density studies, Part A/B
Modified: 6/12/2018
LCD L33273 Bortezomib (Velcade®), Part A/B
Modified: 4/30/2018
LCD L33274 Botulinum Toxins, Part AB
Modified: 4/30/2018
LCD L35698 CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing, Part AB
Modified: 6/12/2018
LCD L33275 Carboplatin (Paraplatin®, Paraplatin-AQ®), Part AB
Modified: 4/30/2018
LCD L36209 Cardiology— non-emergent outpatient testing: exercise stress test, stress echo, MPI SPECT, and cardiac PET, Part AB
Modified: 6/12/2018
LCD L33808 Cataract Extraction, Part B
Modified: 6/12/2018
LCD L33278 Cetuximab (Erbitux®), Part AB
Modified: 4/19/2018
LCD L36617 Chiropractic Services, Part AB
Modified: 6/12/2018
Colorectal Cancer Screening L36355, Part A/B
Modified: 4/19/2018
Revision 6 to LCD L33282 Computed Tomographic Angiography of the Chest, Heart and Coronary Arteries
Modified: 4/19/2018
LCD L33283 Computed Tomographic Colonography, Part AB
Modified: 4/19/2018
LCD L33721 Computed Tomography Scans of the Head or Brain, Part AB
Modified: 4/19/2018
LCD L33284 Computed Tomography of the Abdomen and Pelvis, Part AB
Modified: 4/19/2018
LCD L33285 Computed Tomography of the Thorax, Part AB
Modified: 5/25/2018
LCD L33810 Computerized Corneal Topography, Part B
Modified: 5/28/2018
Controlled Substance Monitoring and Drugs of Abuse Testing (L36393), Part AB
Modified: 6/12/2018
LCD L37561 Cystatin C Measurement, Part A/B
Modified: 5/28/2018
LCD L33571 Destruction of Internal Hemorrhoid(s) by Infrared Coagulation (IRC), Part AB
Modified: 4/19/2018
LCD L33813 Destruction of Malignant Skin Lesions, Part B
Modified: 5/25/2018
LCD L33814 Destruction of Paravertebral Facet Joint Nerve(s), Part B
Modified: 5/25/2018
LCD L33969 Diagnostic Aerosol or Vapor Inhalation, Part A
Modified: 5/11/2018
LCD L33671 Diagnostic Colonoscopy, Part AB
Modified: 4/30/2018
LCD L36232 Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED)
Modified: 5/25/2018
LCD L33903 Diagnostic Laryngoscopy, Part B
Modified: 4/19/2018
LCD L33815 Diagnostic Nasal Endoscopy, Part B
Modified: 6/14/2018
LCD L33583 Diagnostic and Therapeutic Esophagogastroduodenoscopy, Part AB
Modified: 4/19/2018
LCD L33989 Docetaxel (Taxotere®), Part AB
Modified: 4/30/2018
LCD L33722 Doxorubicin, Liposomal (Doxil/Lipodox), Part AB
Modified: 4/24/2018
L33667 Duplex Scan of Lower Extremity Arteries, Part AB
Modified: 4/19/2018
LCD L33674 Duplex Scanning, Part AB
Modified: 5/9/2018
LCD L33816 Duplex scan for erectile dysfunction, Part B
Modified: 5/28/2018
LCD L34043 Dysphagia/Swallowing Diagnosis and Therapy, Part AB
Modified: 5/4/2018
LCD L33817 E&M Home and Domiciliary Visits, Part B
Modified: 6/14/2018
LCD L33669 Electrocardiography, Part AB
Modified: 6/18/2018
LCD L37398 Electroretinography (ERG), Part AB
Modified: 7/20/2018
Emergency and Non-Emergency Ground Ambulance Services (L37697), Part AB
Modified: 5/25/2018
LCD L33906 Epidural, Part B
Modified: 5/28/2018
LCD L36276 Erythropoiesis Stimulating Agents, Part AB
Modified: 5/7/2018
LCD L33723 Etoposide (Etopophos®, Toposar®, Vepesid®, VP-16), Part AB
Modified: 6/14/2018
LCD L36230 Evaluation and Management Services in a Nursing Facility, Part AB
Modified: 4/19/2018
LCD L33818 Excision of Malignant Skin Lesions, Part B
Modified: 5/4/2018
LCD L33661 Flow Cytometry, Part AB
Modified: 5/7/2018
LCD L33997 Fluorescein Angiography, Part AB
Modified: 5/4/2018
LCD L33970 Frequency of Hemodialysis Services, Part A
Modified: 6/7/2018
LCD L33998 Fulvestrant (Faslodex®), Part AB
Modified: 4/19/2018
LCD L33670 Fundus Photography, Part AB
Modified: 4/30/2018
LCD L34002 G-CSF ( Neupogen®, Granix™, Zarxio™), Part AB
Modified: 6/14/2018
LCD L33726 Gemcitabine (Gemzar®)
Modified: 7/5/2018
LCD L33586 Gene Expression Profiling Panel for use in the Management of Breast Cancer Treatment, Part AB
Modified: 5/28/2018
LCD L34912 Genetic Testing for Lynch Syndrome, Part AB
Modified: 5/4/2018
LCD L33834 Health and Behavior Assessment/Intervention, Part B
Modified: 6/14/2018
2018 HCPCS updates effective on 01/01/2018.
Modified: 5/4/2018
LCD L33907 Hepatic (Liver) Function Panel, Part B
Modified: 7/5/2018
LCD L34003 Hepatitis B Surface Antibody and Surface Antigen, Part AB
Modified: 7/12/2018
LCD L33908 High Sensitivity C-Reactive Protein (hsCRP), Part B
Modified: 6/14/2018
LCD L36238 Humanitarian Use Device (HUD) and Humanitarian Device Exemption (HDE) process, Part AB
Modified: 6/14/2018
LCD L36504 Hyperbaric Oxygen (HBO) Therapy, Part AB
Modified: 5/11/2018
LCD L33593 Implantable Infusion Pump for the Treatment of Chronic Intractable Pain, Part AB
Modified: 5/29/2018
LCD L33909 Incision and Drainage of Abscess of Skin, Subcutaneous and Accessory Structures, Part B
Modified: 4/20/2018
LCD L33910 Independent Diagnostic Testing Facility (IDTF), Part B
Modified: 5/11/2018
LCD L33911 Indocyanine - Green Angiography, Part B
Modified: 4/30/2018
LCD L33704 Infliximab (Remicade™), Part AB
Modified: 4/23/2018
LCD L33912 Injection of Trigger Points, Part B
Modified: 5/11/2018
LCD L36773 Intensity Modulated Radiation Therapy (IMRT), Part AB
Modified: 4/23/2018
LCD L34006 Interspinous Process Decompression, Part AB
Modified: 5/28/2018
LCD L34007 Intravenous Immune Globulin, Part AB
Modified: 6/14/2018
LCD L34011 Ionized Calcium, Part AB
Modified: 4/23/2018
LCD L33914 Iridotomy by Laser Surgery, Part B
Modified: 6/14/2018
LCD L33727 Irinotecan, Part AB
Modified: 6/14/2018
LCD L33915 Label and Off-label Coverage of Outpatient Drugs and Biologicals, Part B
Modified: 7/5/2018
LCD L33917 Laser Trabeculoplasty, Part B
Modified: 4/23/2018
LCD L33918 Laser Treatment for Psoriasis, Part B
Modified: 6/14/2018
LCD L34012 Leucovorin (Wellcovorin®), Part AB
Modified: 6/14/2018
LCD L33380 Long-Term Wearable Electrocardiographic Monitoring (WEM), Part AB
Modified: 4/24/2018
Lumbar Spinal Fusion for Instability and Degenerative Disc Conditions(L33382)
Modified: 4/24/2018
LCD L33685 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs, Part AB
Modified: 6/18/2018
LCD L34014 Magnesium, Part AB
Modified: 4/23/2018
LCD L34372 Magnetic Resonance Angiography (MRA), Part AB
Modified: 4/23/2018
LCD L34373 Magnetic Resonance Imaging (MRI) of Any Joint of the Lower Extremities, Part B
Modified: 4/23/2018
LCD L34377 Magnetic Resonance Imaging of Upper Extremity, Part AB
Modified: 5/9/2018
LCD L34374 Magnetic Resonance Imaging of the Brain, Part AB
Modified: 4/17/2018
LCD L34375 Magnetic Resonance Imaging of the Orbit, Face, and/or Neck, Part AB
Modified: 4/19/2018
LCD L34376 Magnetic Resonance Imaging of the Spine, Part AB
Modified: 4/23/2018
LCD L33618 Major Joint Replacement (Hip and Knee), Part AB
Modified: 5/28/2018
LCD L33594 Manipulation Under Anesthesia (MUA)
Modified: 6/18/2018
LCD L33689 Mohs Micrographic Surgery (MMS), Part AB
Modified: 5/28/2018
Molecular Pathology Procedures (L34519), Part AB
Modified: 5/28/2018
LCD L34518 Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) Typing, Part AB
Modified: 5/29/2018
LCD L33595 Monitored Anesthesia Care (MAC) for Certain Interventional Pain Management Services, Part AB
Modified: 4/23/2018
LCD L33922 Nail Debridement, Part B
Modified: 7/5/2018
LCD L34859 Nerve Conduction Studies and Electromyography, Part AB
Modified: 6/18/2018
LCD L33693 Non-Invasive Evaluation of Extremity Veins, Part AB
Modified: 5/28/2018
LCD L33695 Non-invasive Extracranial Arterial Studies, Part AB
Modified: 5/28/2018
LCD L33296 Noncovered Procedures - Endoscopic Treatment of Gastroesophageal Reflux Disease (GERD), Part AB
Modified: 7/5/2018
LCD L33777 Noncovered Services, Part AB
Modified: 5/29/2018
LCD L33923 Noninvasive Ear or Pulse Oximetry For Oxygen Saturation, Part B
Modified: 7/6/2018
LCD L33696 Noninvasive Physiologic Studies of Upper or Lower Extremity Arteries, Part AB
Modified: 7/5/2018
LCD L33924 Omalizumab (Xolair®), Part B
Modified: 5/25/2018
LCD L33925 Ophthalmological Diagnostic Services, Part B
Modified: 7/5/2018
LCD L34017 Ophthalmoscopy, Part AB
Modified: 5/25/2018
LCD L33927 Optical Coherence Biometry, Part B
Modified: 5/25/2018
LCD L33929 Osteopathic Manipulative Treatment, Part B
Modified: 5/28/2018
LCD L33729 Oxaliplatin (Eloxatin®), Part AB
Modified: 5/28/2018
LCD L33730 Paclitaxel (Taxol®), Part AB
Modified: 5/28/2018
LCD L34018 Parathormone (Parathyroid Hormone), Part AB
Modified: 5/25/2018
LCD L33930 Paravertebral Facet Joint Blocks, Part B
Modified: 5/28/2018
LCD L33747 Pegfilgrastim (Neulasta®), Part AB
Modified: 4/23/2018
LCD L33978 Pemetrexed, Part AB
Modified: 5/2/2018
LCD L33933 Peripheral Nerve Blocks, Part B
Modified: 5/25/2018
LCD L33934 Physician Certification and Recertification of Home Health Services, Part B
Modified: 4/30/2018
LCD L33405 Polysomnography and Sleep Testing, Part AB
Modified: 5/25/2018
LCD L33935 Post-Voiding Residual Ultrasound, Part B
Modified: 4/23/2018
LCD L33406 Posterior Tibial Nerve Stimulation (PTNS), Part AB
Modified: 5/28/2018
LCD L36775 Prostatic Urethral Lift (PUL), Part AB
Modified: 4/11/2018
LCD L33937 Proton Beam Radiotherapy, Part B
Modified: 5/28/2018
LCD L33252 Psychiatric Diagnostic Evaluation and Psychotherapy Services, Part AB
Modified: 4/30/2018
LCD 33975 Psychiatric Inpatient Hospitalization, Part A
Modified: 6/22/2018
L33972 Psychiatric Partial Hospitalization Program, Part A
Modified: 5/28/2018
LCD L34520 Psychological and Neuropsychological Tests, Part AB
Modified: 4/17/2018
LCD Pulmonary Diagnostic Services (L33707), Part AB
Modified: 4/24/2018
LCD L33538 Radiation Therapy for T1 Basal Cell and Squamous Cell Carcinomas of the Skin, Part AB
Modified: 4/24/2018
LCD L33939 Reduction Mammaplasty, Part B
Modified: 5/28/2018
LCD L33745 Respiratory Therapeutic Services, Part AB
Modified: 5/28/2018
LCD L33746 Rituximab (Rituxan®), Part AB
Modified: 7/5/2018
LCD L33748 Romiplostim (Nplate®), Part AB
Modified: 5/25/2018
LCD L33941 Routine Foot Care, Part B
Modified: 4/23/2018
LCD L36296 Sacral Neuromodulation, Part B
Modified: 7/5/2018
LCD L33957 Sacroiliac Joint Injection, Part B
Modified: 7/5/2018
LCD L33751 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI), Part AB
Modified: 5/11/2018
Screening and Diagnostic Mammography (L36342), Part A/B
Modified: 4/23/2018
LCD L34021Sedimentation Rate, Erythrocyte, Part AB
Modified: 4/30/2018
LCD L34022 Serum Phosphorus, Part AB
Modified: 5/28/2018
LCD L33600 Sinus X-ray(s), Part AB
Modified: 5/28/2018
LCD L33958 Somatosensory Testing, Part B
Modified: 4/30/2018
LCD L34521 Special EEG Tests, Part AB
Modified: 4/30/2018
LCD L36234 Special Histochemical Stains and Immunohistochemical Stains, Part AB
Modified: 4/30/2018
LCD L36035 Spinal Cord Stimulation for Chronic Pain, Part AB
Modified: 5/28/2018
LCD L33410 Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT), Part AB
Modified: 5/28/2018
LCD L34023 Strapping, Part AB
Modified: 5/28/2018
LCD L34025 Surgical Decompression for Peripheral Polyneuropathy, Part AB
Modified: 7/5/2018
LCD L33411 Surgical Management of Morbid Obesity, Part AB
Modified: 5/28/2018
LCD L33833 Surgical Treatment of Nails, Part B
Modified: 7/5/2018
LCD L33755 Susceptibility Studies, Part AB
Modified: 5/28/2018
LCD L33754 Syphilis Test, Part AB
Modified: 7/13/2017
Modified: 4/30/2018
LCD L33412 Testosterone pellets (Testopel®), Part AB
Modified: 4/30/2018
LCD L33961 Therapy Services billed by Physicians/Nonphysician Practitioners, Part B
Modified: 4/30/2018
LCD L33413 Therapy and Rehabilitation Services, Part AB
Modified: 5/28/2018
LCD L33752 Topotecan Hydrochloride (Hycamtin®), Part AB
Modified: 5/28/2018
Revision 4 to LCD L34031 Total Calcium, Part AB
Modified: 4/30/2018
LCD L33977 Transcranial Doppler Studies, Part B
Modified: 7/5/2018
LCD L34522 Transcranial Magnetic Stimulation for Major Depressive Disorder, Part AB
Modified: 5/2/2018
LCD L33756 Transesophageal Echocardiogram, Part AB
Modified: 4/17/2018
LCD L33768 Transthoracic Echocardiography (TTE), Part AB
Modified: 5/28/2018
LCD L34026 Trastuzumab (Herceptin®), Part AB
Modified: 7/20/2018
L33762 Treatment of varicose veins of the lower extremity, Part AB
Modified: 5/28/2018
LCD L33974 Troponin, Part A
Modified: 5/28/2018
LCD L34027 Ultrasound, Soft Tissues of Head and Neck, Part AB
Modified: 7/5/2018
LCD L34028 Upper Eyelid and Brow Surgical Procedures, Part AB
Modified: 4/19/2018
LCD L34029 Urinalysis, Part AB
Modified: 7/5/2018
LCD L33965 Urinary Tumor Markers for Bladder Cancer, Part B
Modified: 5/28/2018
LCD L36962 Vascular Endothelial Growth Factor Inhibitors for the Treatment of Ophthalmological Diseases, Part AB.
Modified: 5/2/2018
LCD L33763 Vascular Stenting of Lower Extremity Arteries, Part AB
Modified: 4/17/2018
LCD L34976 Vertebroplasty, Vertebral Augmentation; Percutaneous, Part AB
Modified: 5/28/2018
LCD L33966 Vestibular Function Tests, Part B
Modified: 5/28/2018
LCD L33767 Viscosupplementation Therapy for Knee, Part AB
Modified: 5/28/2018
LCD L33766 Visual Field Examination, Part AB
Modified: 7/5/2018
LCD L33967 Vitamin B12 Injections, Part B
Modified: 5/28/2018
LCD L33771 Vitamin D; 25 hydroxy, includes fraction(s), if performed, Part AB
Modified: 7/5/2018
LCD L33774 Wireless Capsule Endoscopy, Part AB
Modified: 4/17/2018
(LCD): Wound Care (L37166), Part AB
Modified: 7/5/2018
LCD L33968 Yag Laser Capsulotomy, Part B
First Coast Service Options (First Coast) strives to ensure that the information available on our provider website is accurate, detailed, and current. Therefore, this is a dynamic site and its content changes daily. It is best to access the site to ensure you have the most current information rather than printing articles or forms that may become obsolete without notice.